Study of Gemcitabine and Vinorelbine in Soft Tissue Sarcomas

NCT00134641 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Sarcoma, Soft Tissue

Interventions

DRUG: gemcitabine
DRUG: vinorelbine

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]
[object Object]